Amphora Discovery Overview

  • Founded
  • 2001
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

Amphora Discovery General Information

Description

Provider of pathway-based drug discovery services. The company's lead generation platform delivers unmatched precision, selectivity and data quality, which has produced well characterized proprietary new clinical entities for use in oncology, inflammation, metabolic diseases and neurological disorders. Amphora's most advanced compounds are preclinical candidates in the areas of oncology and inflammation which are exquisitely specific inhibitors for AKT1 and p38 respectively.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Discovery Tools (Healthcare)
Acquirer
Nanosyn
Primary Office
  • 800 Capitola Drive
  • Suite 4
  • Durham, NC 27713
  • United States
+1 (919) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Amphora Discovery Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 21-Oct-2008 000.00 Completed Generating Revenue
5. Later Stage VC (Series E) 01-Feb-2006 00.000 000.00 00000 Completed Generating Revenue
4. Later Stage VC (Series D) 30-May-2005 00.00 000.00 00000 Completed Generating Revenue
3. Later Stage VC (Series C) 08-Dec-2004 0000 0000 0000 Completed Generating Revenue
2. Early Stage VC (Series B) 01-Dec-2002 $23M $48M 000.00 Completed Generating Revenue
1. Early Stage VC (Series A) 01-Jan-2001 $25M $25M 0000 Completed Product Development
To view Amphora Discovery’s complete valuation and funding history, request access »

Amphora Discovery Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series E1 0,000,000 00.000000 00.00 00.00 00.00 00 00.00
Series E 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series D 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series C 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series B 00,000,000 00.000000 00.00 00.0 00.0 00 00.00 00.000
Series A1 23,750,000 $0.001000 $0.08 $1 $1 1x $0.71 20.22%
Series A 1,300,000 $0.001000 $0.08 $100000
To view Amphora Discovery’s complete cap table history, request access »

Amphora Discovery Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
3i Group PE/Buyout Minority 000 0000 000000 0
ARCH Venture Partners Venture Capital Minority 000 0000 000000 0
Aventis Corporation Minority 000 0000 000000 0
CW Group Venture Capital Minority 000 0000 000000 0
Chevron Technology Ventures Corporate Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »